Molecular targets and therapeutic interventions in non-small cell lung cancer treatment
Molecular targets and therapeutic interventions in non-small cell lung cancer treatment. The depicted schematic provides a concise overview of the key molecular targets in NSCLC and the suite of targeted therapies designed to intervene. It encompasses a spectrum of inhibitors for pathways such as EGFR, ALK, VEGFR, MET, and RET, as well as agents that modulate the KRAS, BRAF, MEK, and the PI3K/AKT/mTOR cascades. Featured as well are the CDK4/6 inhibitors, a novel class of drugs that govern cell cycle progression. Each therapeutic agent is specified by its target, underscoring the targeted approach integral to contemporary NSCLC treatment paradigms
Publication
Advancements in NSCLC (2024) Jianan Xu, et al. Am J Clin Oncol. 2024 Jun;47(6). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | VEGFR | VEGFR | ncbigene_synonym | KDR | 3791 |
| Homo sapiens | Primates | VEGFR | VEGFR | famplex_relations | FLT1 | 2321 |
| Homo sapiens | Primates | VEGFR | VEGFR | famplex_relations | FLT4 | 2324 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | ALK | ALK | ncbigene_symbol | ALK | 238 |
| Homo sapiens | Primates | VEGF | VEGF | ncbigene_synonym | VEGFA | 7422 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFB | 7423 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFC | 7424 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFD | 2277 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | PGF | 5228 |
| Homo sapiens | Primates | RET | RET | ncbigene_symbol | RET | 5979 |
| Homo sapiens | Primates | EML4 | EML4 | ncbigene_symbol | EML4 | 27436 |
| Homo sapiens | Primates | STAT | STAT | ncbigene_synonym | SOAT1 | 6646 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT1 | 6772 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT2 | 6773 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT3 | 6774 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT4 | 6775 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT6 | 6778 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT5A | 6776 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT5B | 6777 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK1 | 3716 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK2 | 3717 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK3 | 3718 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | TYK2 | 7297 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_symbol | KRAS | 3845 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_synonym | NRAS | 4893 |
| Homo sapiens | Primates | BRAF | BRAF | ncbigene_symbol | BRAF | 673 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | CyclinD | CYCLIND | famplex_relations | CCND1 | 595 |
| Homo sapiens | Primates | CyclinD | CYCLIND | famplex_relations | CCND2 | 894 |
| Homo sapiens | Primates | CyclinD | CYCLIND | famplex_relations | CCND3 | 896 |
| Homo sapiens | Primates | CDK4/6 | CDK4 | ncbigene_symbol | CDK4 | 1019 |
| Homo sapiens | Primates | CDK4/6 | CDK6 | ncbigene_symbol | CDK6 | 1021 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | ERK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | ERK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F1 | 1869 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F2 | 1870 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F3 | 1871 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F4 | 1874 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F5 | 1875 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F6 | 1876 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F7 | 144455 |
| Homo sapiens | Primates | E2F | E2F | famplex_relations | E2F8 | 79733 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Homo sapiens | Primates | ROS1 | ROS1 | ncbigene_symbol | ROS1 | 6098 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| MET | Met | methionine | chebi:16811 | |
| Crizotinib | crizotinib | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine | chebi:64310 | |
| Crizotinib | crizotinib | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine | chebi:64310 | |
| Capmatinib | Capmatinib | chebi:231693 | ||
| Ceritinib | ceritinib | 5-chloro-N(2)-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N(4)-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine | chebi:78432 | |
| Alectinib | alectinib | 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | chebi:90936 | |
| Savolitinib | savolitinib | 1-[(1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine | chebi:231369 | |
| Lorlatinib | lorlatinib | (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile | chebi:143117 | |
| Dabrafenib | dabrafenib | N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide | chebi:75045 | |
| Trametinib | trametinib | N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide | chebi:75998 | |
| MEK | MEK | butan-2-one | chebi:28398 | |
| Sotorasib | sotorasib | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one | chebi:178199 | |
| Palbociclib | palbociclib | 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one | chebi:85993 | |
| Everolimus | everolimus | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:68478 | |
| Sirolimus | sirolimus | (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone | chebi:9168 | |
| Crizotinib | crizotinib | 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine | chebi:64310 | |
| Entrectinib | entrectinib | N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide | chebi:195558 | |
| Lorlatinib | lorlatinib | (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile | chebi:143117 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|